Follow Attend Connect
Mon | Tue | Wed | Thu | Fri | Sat | Sun |
---|---|---|---|---|---|---|
25
Date :
Monday, 25 February 2019
|
26
Date :
Tuesday, 26 February 2019
|
Venue: BRUEGEL | City: Saint-Josse-ten-Noode
Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.
It has been a long standing ambition of the Commission to improve the patent system in Europe, to ensure incentives to innovate in a single European market and support EU firms’ global competitiveness. For products subject to regulated market authorisations, such as pharmaceuticals, compulsory and lengthy testing and clinical tries that products require prior to obtaining regulatory marketing approval reduces the effective patent protection. To offset this loss, Supplementary Protection Certificate (SPC) grants an extension of up to five years to the term of a patent right (of twenty years). This SPC protection is currently being evaluated in terms of its fit to a changing global trade and innovation model.
This event will look at both the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as the economic effects which the current system may have had. While reviewing any changes in the global innovation structure of the pharmaceutical industry, we will discuss possible re-calibrations.
This event will be livestreamed at 13:00 CET. There is no need to register for the livestream.
SCHEDULE
12:30-13:00 Check-in and lunch
13:00-14:00 Panel discussion
Chair: Reinhilde Veugelers, Senior Fellow
Christian Jervelund, Head Health Care and Life Sciences services, Copenhagen Economics
Margaret K. Kyle, Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)
Roberto Romandini, Senior Research Fellow, Max Planck Institute for Innovation and Competition
Amaryllis Verhoeven, Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission
Bruno van Pottelsberghe, Non-Resident Fellow
Additional speakers to be confirmed
14:00-14:30 Q&A
14:30 End
Powered by iCagenda